Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating fatigue syndrome and preventing presenility, and preparation method thereof

A technology for fatigue syndrome and medicine, which is applied in the treatment of fatigue syndrome and the medicine for preventing premature aging. The effect of preventing premature aging

Inactive Publication Date: 2005-07-06
张志美
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the therapeutic drugs used for such diseases at home and abroad are often lack of pertinence. At the same time, due to the high price, patients cannot adhere to long-term medication, making it difficult to maintain the therapeutic effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

experiment example 2

[0046] [Experimental Example 2] Curative Effect Observation of Medicine Auxiliary Treatment of AIDS of the present invention

[0047] Therapeutic drugs: 0.5 g / granule of drug capsules of the present invention, dideoxycytidine and interleukin.

[0048] Treatment method: using the control method, 12 patients, the shortest time of illness is 8 months, the longest is 3 years and 6 months, the oldest is 48 years old, and the youngest is 36 years old. Select 6 cases who have been ill for more than 2 years, have many complications, and are over 40 years old as the treatment group, and the remaining 6 cases as the control group. The treatment group took 2 capsules of the present invention and 2 capsules of dideoxycytidine orally, 3 times a day; the control group took 2 tablets of dideoxycytidine and interleukin, 3 times a day. After 6 months of treatment, the comparative results are shown in Table 3.

[0049] Group

do not

general symptoms

re...

Embodiment 1

[0052] [embodiment 1] capsule preparation of medicine of the present invention

[0053] (1) Take by weighing 3 kilograms of emblica emblica, 2 kilograms of Gynostemma pentaphylla, 1.5 kilograms of ganoderma lucidum, 2 kilograms of astragalus and 1.5 kilograms of Schisandra chinensis, and set aside;

[0054] (2) Washing the emblica, squeezing the juice, concentrating under reduced pressure into an extract, and drying to obtain the emblica extract;

[0055] (3) Add water to decoct Gynostemma pentaphyllum for three times, and it is advisable to add water each time to cover the surface of the medicine, combine three times of decoction, filter to obtain filtrate, concentrate the filtrate into an extract with a specific gravity of 1.30, and add three times the amount of 90%~ 95% ethanol is used for alcohol precipitation, the ethanol is recovered and concentrated, and dried at 50°C to 80°C to obtain Gypenoside extract;

[0056](4) Ganoderma lucidum, astragalus and schisandra were cr...

Embodiment 2

[0058] [embodiment 2] tablet preparation of medicine of the present invention

[0059] (1) Weigh 3 kg of emblica, 2 kg of gynostemma, 1.5 kg of ganoderma lucidum, 2 kg of astragalus and 1.5 kg of schisandra, and set aside;

[0060] (2) Washing the emblica, squeezing the juice, concentrating under reduced pressure into an extract, and drying to obtain the emblica extract;

[0061] (3) Add water to decoct Gynostemma pentaphyllum for three times, and it is advisable to add water each time to cover the surface of the medicine, combine three times of decoction, filter to obtain filtrate, concentrate the filtrate into an extract with a specific gravity of 1.30, and add three times the amount of 90%~ 95% ethanol is used for alcohol precipitation, the ethanol is recovered and concentrated, and dried at 50°C to 80°C to obtain Gypenoside extract;

[0062] (4) Ganoderma lucidum, astragalus and schisandra were crushed with a pulverizer and mixed evenly, and 60% to 80% ethanol was added f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating fatigue syndrome and preventing presenility, which is prepared from emblic leafflower fruit, gynostemma pentaphylla, and glossy ganoderma a finite of weight ratio proportion. The medicine can be prepared into any of the conventional oral administration dosage.

Description

technical field [0001] The invention relates to a Chinese patent medicine prepared from Chinese herbal medicines, and more specifically relates to a medicine for treating fatigue syndrome and preventing premature aging. The invention also relates to a preparation method of the medicine. Background technique [0002] The theory of traditional Chinese medicine believes that fatigue syndrome and premature aging are caused by deficiency of spleen and kidney, deficiency of both qi and blood, disharmony between heart and kidney, and failure of vital energy. , Dull face, premature gray hair or hair loss, susceptible to exogenous evils and other diseases. Western medicine, on the other hand, refers to this kind of decreased immune function and body dysfunction caused by long-term fatigue as a sub-health state, and believes that many diseases such as high blood pressure, diabetes, and heart and brain arteriosclerosis are related to this. [0003] At present, the therapeutic drugs u...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/48A61P43/00
Inventor 张志美张怡
Owner 张志美
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com